Evidence mapPaperPMID 41563804Full record

ArticleJournal of the American Society of Nephrology : JASN2026

Glis3 Is a Modifier of Cyst Progression in Autosomal Dominant Polycystic Kidney Disease.

Zemeng Wei, Jianlei Gu, Xin Tian, Chao Zhang, Hongyu Zhao, Stefan Somlo

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Zemeng WeiDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.ORCID 0000-0002-4865-3866
Jianlei GuDepartment of Biostatistics, Yale University School of Public Health, New Haven, Connecticut.ORCID 0000-0002-9337-5017
Xin TianDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.ORCID 0009-0003-1616-9097
Chao ZhangDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.ORCID 0009-0009-0451-3077
Hongyu ZhaoDepartment of Genetics, Yale School of Medicine, New Haven, Connecticut.ORCID 0000-0003-1195-9607
Stefan SomloDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.ORCID 0000-0001-5062-4629

Funding

GENETICS AND GENOMICS OF HUMAN DISEASET32HD007149 · YALE UNIVERSITY · 1985 to 2025
$2.2M
Amy P. Goldman Foundation grantNICHD NIH HHS T32 HD007149NIDDK NIH HHS DK100592NIDDK NIH HHS DK120534NIDDK NIH HHS DK120911
6 · The paper itself

Abstract

key pointsDual inactivation of Glis3 and Pkd1 exacerbated polycystic kidney disease compared with Pkd1 inactivation alone in mouse models of autosomal dominant polycystic kidney disease. RNA-Seq and ATAC-Seq suggested Glis3 inactivation resulted in dysregulated fatty acid metabolism and alteration of circadian regulation. Glis3 was involved in a transcriptional network consisting of the transcription factors HNF1 homeobox B, hepatic nuclear factor 4, alpha, and D site albumin promoter binding protein.

backgroundAutosomal dominant polycystic kidney disease is caused by mutations affecting polycystin-1 or polycystin-2. The existence of a cilia-dependent cyst activation pathway has been identified by showing that structurally intact primary cilia are crucial for rapid cyst growth following loss of polycystins. We previously used translating ribosome affinity purification RNA-Seq on precystic mouse kidneys to determine a translatome that meets the criteria for cilia-dependent cyst activation. From this, we identified Glis2 as an early effector of polycystin signaling and a potential target for therapy. Here, we investigate the role of Glis3 which, while not transcriptionally altered in autosomal dominant polycystic kidney disease models, encodes a cilia-localized transcription factor belonging to the same gene family as Glis2 .

methodsWe used live cell imaging along with gene and protein expression studies to determine the relationships between Glis3, Glis2, and polycystin-1 expression. We used Glis3 conditional knockout mice to investigate the in vivo genetic interaction between Glis3 and Pkd1 . We used gene expression and chromatin accessibility analyses by RNA-Seq and ATAC-Seq, respectively, on an allelic series of Glis3 and Pkd1 inactivation models to explore the genetic relationships between the two genes.

resultsThe ciliary localization of Glis3 was not affected by Pkd1 mutation status. Kidney selective inactivation of Glis3 by itself did not affect kidney structure or function, but dual inactivation of Glis3 and Pkd1 significantly worsened polycystic kidney disease. Integration of transcriptomic profiling and chromatin accessibility assays suggested that kidney tubule-specific Glis3 inactivation resulted in dysregulated fatty acid metabolism and alteration of circadian regulation.

conclusionsGlis3 is a primary cilium localized transcription factor that genetically interacts with Pkd1 and modifies kidney epithelial cell metabolism and circadian function.

Indexed as

Polycystic Kidney, Autosomal DominantTranscription FactorsAnimalsCiliaDisease Models, AnimalDisease ProgressionMiceTRPP Cation ChannelsTranscription FactorsTRPP Cation Channelscystic kidneycystic kidney diseasegenetic kidney diseasegene transcriptionpolycystic kidney diseasetranscription factors

Identifiers

PMID41563804
PMCPMC13337165

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.